N
NXNN
vs
S&P 500
S&P 500
Over the past 12 months, NXNN has underperformed S&P 500, delivering a return of 0% compared to the S&P 500's +26% growth.
Stocks Performance
NXNN vs S&P 500
Performance Gap
NXNN vs S&P 500
Performance By Year
NXNN vs S&P 500
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Nexeon Medsystems Inc
Glance View
Nexeon MedSystems, Inc. is a medical device company, which focuses on the development, manufacturing, and commercialization of neurostimulation technology for the treatment of various neurological disorders through electrical stimulation of neural tissues. The company is headquartered in West Palm Beach, Florida. The company went IPO on 2017-08-01. The Company’s developing technology solutions device including electronics, software, mechanical engineering, and material science, as well as pharmaceuticals, protein chemistry, and cell biology. In addition, the Company is developing and commercializing NNS, an implantable neurostimulation and recording platform. The Company’s wholly-owned subsidiaries include Nexeon Medsystems Europe, SARL (Nexeon Europe), Nexeon Medsystems Puerto Rico Operating Company Corporation (NXPROC) and Pulsus Medical LLC.
